semaglutide is fda approved Approval vs Compounded Alternatives Big news in weight loss

These support research into GH pathway modulation

A major clinical study found that people who stopped taking semaglutide after one year regained about two-thirds of their lost weight, while those who continued treatment maintained their results

Throughout 2024 and 2025, Lilly and Novo waged aggressive litigation campaigns to shut down compounding pharmacies selling knockoff versions of their drugs for $130-200 per month, arguing the copycat products posed safety risks and violated FDA rules

You can read more about genes linked to Hashimotos (and how genes are only 25 percent of the equation!) at the linked article

individuals with retinopathy prior to the index event were excluded from the retinopathy outcome analysis, etc.)